Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 12826 - 12850 of 14359 in total
Palucorcel is an investigational stem cell therapy consisting of human umbilical tissue-derived cells. Developed by Janssen Biotech, it is being investigated for the treatment of various conditions such as amyotrophic lateral sclerosis (ALS) and macular degeneration.
Investigational
Matched Description: … being investigated for the treatment of various conditions such as amyotrophic lateral sclerosis (ALS) and
RPI-MN is a detoxified or chemically modified alpha-cobratoxin with antiviral properties. Being developed by Nutra Pharma under the trade name PEPTERON, it is being investigated for the treatment of neurological and immune disorders.
Investigational
Matched Description: … Nutra Pharma under the trade name PEPTERON, it is being investigated for the treatment of neurological and
SRP-9005 is a rAAVrh74 vector containing a codon-optimized human SGCG transgene. Developed by the Kurt+Peter Foundation and Sarepta Therapeutics, it is being investigated for the treatment of Limb-girdle muscular dystrophy (LGMD) type 2C/R5.
Investigational
Matched Description: … Developed by the Kurt+Peter Foundation and Sarepta Therapeutics, it is being investigated for the treatment …
Investigational
Investigational
Viralym-C is an investigational T-cell immunotherapy developed by ViraCyte. It consists of Human Leukocyte Antigen (HLA)-matched cytomegalovirus (CMV)-specific T lymphocytes. It was granted FDA orphan designation in January 2017 and investigated for the treatment of CMV infection.[A260291, L47241]
Investigational
Matched Description: … It was granted FDA orphan designation in January 2017 and investigated for the treatment of CMV infection …
Investigational
Investigational
Investigational
RGLS-8429 is an investigational anti-miR-17 oligonucleotide.
Investigational
SGN-1 is a genetically modified strain of Salmonella enterica comprising methioninase.
Investigational
Briquilimab is a humanized aglycosylated IgG1 kappa monoclonal antibody targeting CD117 (cKit).
Investigational
Investigational
Investigational
CLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.
Investigational
SER-287 comprises healthy microbiome-derived Gram positive bacterial spores.
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Investigational
Displaying drugs 12826 - 12850 of 14359 in total